Joel Greenblatt’s CorMedix CRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding CRMD
Joel Greenblatt's CRMD Position: Q3 2026 in Review
Joel Greenblatt sold out of CorMedix (CRMD) in Q3 2026, closing a stake of 22,400 shares — an estimated $176K sold.
Joel Greenblatt first reported a position in CRMD in Q3 2025 and held it in 4 quarters. The position peaked at $365K in Q3 2025. 189 funds tracked by Wall St. Rank hold CRMD as of Q3 2026.
- Joel Greenblatt reported no remaining CorMedix position as of Q3 2026 after selling out during the quarter.
- Joel Greenblatt sold 22,400 CorMedix shares in Q3 2026, an estimated $176K.
- Joel Greenblatt first reported a position in CorMedix in Q3 2025 and held it in 4 quarters.
- Joel Greenblatt's CorMedix position peaked at $365K in Q3 2025.
- 189 funds tracked by Wall St. Rank held CorMedix as of Q3 2026.
Based on Gotham Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.